Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950172-04-002193
Filing Date
2004-09-20
Accepted
2004-09-20 13:49:02
Documents
1
Effectiveness Date
2004-09-20

Document Format Files

Seq Description Document Type Size
1 neo14a.txt DEFA14A 6861
  Complete submission text file 0000950172-04-002193.txt   8408
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: DEFA14A | Act: 34 | File No.: 001-12493 | Film No.: 041037240
SIC: 2836 Biological Products, (No Diagnostic Substances)